Elsevier launches an AI tool to support faster and more reliable access to regulatory insights for drug development

Mirit Eldor, Managing Director, Life Sciences Solutions at Elsevier

Credit: Elsevier

The solution transforms how insights are gathered from regulatory data, enabling users to identify critical precedents quickly, anticipate approval issues and avoid costly missteps

Register for FREE to keep reading

Join 12,000+ scientists, engineers, and IT professionals driving innovation through informatics, HPC, and simulation with:

Insights into HPC, AI, lab informatics & data
Curated content for life sciences, engineering & academia
Access to Breakthroughs: real-world computing success
Free reports & panels, including the Lab Informatics Guide
White Papers & software updates for smarter research

Sign up now

Already a member? Log in here

Your data is protected under our privacy policy.

The convergence of HPC and AI: Innovation in the post-Moore’s Law era

At the ISC High Performance 2025 event hosted in Hamburg, Germany, speakers discussed how innovation in HPC and AI technology is driving new innovation that aims to keep pace with Moore's Law as shrinking transistors becomes more expensive and extremely difficult.